Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 21;14:3417–3427. doi: 10.2147/DDDT.S256813

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

IncRNA XIST targeted miR-200a-3p to up-regulate NRP1 expression. (A) NRP1 expression in cancer tissues and adjacent tissues. The diagnostic AUC of NRP1 was > 0.8. (B) Compared with ARPE-19, NRP1 was significantly up-regulated in Y79. (C) NRP1 was significantly down-regulated in high/medium differentiation tissues than that in low differentiation tissues. (D) NRP1 expression after transfection with Y79. (E) Luciferase activity of Y79; (F) XIST was negatively correlated with miR-200a-3p (r= −0.8883, P<0.001). (G) MiR-200a-3p was negatively correlated with NRP1 (r= −0.9123, P<0.001). (H) XIST was positively correlated with NRP1 expression (r= 0.8760, P<0.001).

Note: ^aIndicates P<0.001.